India Equity Analysis, Reports, Recommendations, Stock Tips and more!
Search Now
Recommendations
Tuesday, April 22, 2014
Paper Products drops ex-dividend
Paper Products lost 0.91% to Rs 108.90 at 11:37 IST on BSE as the stock turned ex-dividend today, 22 April 2014, for dividend of Rs 2.80 per share for the year ended 31 December 2013.
Meanwhile, the S&P BSE Sensex was up 38.92 points or 0.17% at 22,803.75.
On BSE, so far 23,000 shares were traded in the counter as against average daily volume of 80,710 shares in the past one quarter.
The stock hit a high of Rs 109.60 and a low of Rs 107 so far during the day. The stock had hit a record high of Rs 111.90 on Monday, 21 April 2014. The stock had hit a 52-week low of Rs 56.50 on 29 April 2013.
The stock had outperformed the market over the past one month till 21 April 2014, surging 18.68% compared with the Sensex's 4.65% rise. The scrip had also outperformed the market in past one quarter, jumping 51.07% as against Sensex's 7.12% rise.
The small-cap company has equity capital of Rs 12.54 crore. Face value per share is Rs 2.
Before turning ex-dividend, the stock offered a dividend yield of 2.54% based on the closing price of Rs 109.90 on Monday, 21 April 2014.
On a consolidated basis, Paper Products' net profit surged 66.1% to Rs 16.66 crore on 22.6% growth in net sales to Rs 279.02 crore in Q4 December 2013 over Q4 December 2012.
Paper Products offers a wide portfolio of packaging solutions that include flexible packaging, labeling technologies and specialized cartons.
Supreme Petrochem slips after weak Q3 outcome
Supreme Petrochem fell 4.06% to Rs 63.75 at 10:40 IST on BSE after net profit slumped 62.84% to Rs 9.78 crore on 4.23% increase in net total income from operations to Rs 823.40 crore in Q3 March 2014 over Q3 March 2013.
The company made the announcement after market hours on Monday, 21 April 2014.
Meanwhile, the BSE Sensex was up 42.72 points, or 0.19%, to 22,807.55.
On BSE, so far 68,000 shares were traded in the counter, compared with an average volume of 19,993 shares in the past one quarter.
The stock hit a high of Rs 65.90 and a low of Rs 62.10 so far during the day. The stock hit a 52-week high of Rs 70.50 on 13 May 2013. The stock hit a 52-week low of Rs 50.95 on 26 February 2014.
The stock had outperformed the market over the past one month till 21 April 2014, rising 22.49% compared with the Sensex's 4.65% rise. The scrip had also outperformed the market in past one quarter, rising 18.34% as against Sensex's 7.12% rise.
The small-cap company has an equity capital of Rs 96.84 crore. Face value per share is Rs 10.
In a separate announcement on Monday, 21 April 2014, Supreme Petrochem said that its board has approved buyback of the company's fully paid-up equity shares from open market through the stock exchange mechanism, for an amount not exceeding Rs 33.75 crore. The maximum buyback price is set at Rs 70 per equity share. The company said it would buyback a maximum of 60 lakh equity shares and a minimum of 24.10 lakh equity shares. The company said it would utilise minimum of Rs 16.875 crore, which is 50% of the buyback size, for the buyback plan.
Supreme Petrochem (SPL), owns and operates a polystyrene facility, with an installed capacity of 2,72,000 tonnes per annum (TPA) in Raigad. The facility also includes a colouring and compounding facility with an installed capacity of 25000 TPA.
Strides Arcolab gains after clarification on supply of drugs to Vietnam
Strides Arcolab rose 0.8% to Rs 464.50 at 14:14 IST on BSE after the company in a clarification said that there is no ban on the company to supply drugs to Vietnam and the company continues to export drugs to Vietnam.
The clarification was issued during trading hours today, 22 April 2014.
Meanwhile, the S&P BSE Sensex was up 18.65 points or 0.08% at 22,783.48.
On BSE, so far 72,000 shares were traded in the counter as against average daily volume of 72,423 shares in the past one quarter.
The stock was volatile. The stock rose as much as 2.21% at the day's high of Rs 471 so far during the day. The stock lost as much as 0.61% at the day's low of Rs 457.95 so far during the day.
The stock had outperformed the market over the past one month till 21 April 2014, surging 28.21% compared with the Sensex's 4.65% rise. The scrip had also outperformed the market in past one quarter, jumping 22.7% as against Sensex's 7.12% rise.
The company has equity capital of Rs 59.57 crore. Face value per share is Rs 10.
Strides Arcolab in its clarification with regard to the news article appearing in a leading financial daily wherein it was stated that Vietnam has banned 45 companies including Strides Arcolab from supplying medicines to its market (titled "Vietnam declare war on India Pharma Companies"), said that there is no ban on Strides Arcolab to supply drugs to Vietnam and the company continues to export drugs to Vietnam. Further, Vietnam is a low priority market for Strides Arcolab with sales under $200,000 per annum, the company added.
Strides Arcolab's net profit galloped 4668.3% to Rs 3525.24 crore on 58% growth in net sales to Rs 240.24 crore in Q4 December 2013 over Q4 December 2012.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore. The company develops and manufactures a wide range of IP-led niche pharmaceutical products. The company has 5 manufacturing facilities, presence in more than 75 countries in developed and emerging markets.
Subscribe to:
Posts (Atom)